Sign In
Buy ZYXI
$0.125
+0 (+0%)
At Close: Mar 20, 2026
NEW YORK CITY, NY / ACCESS Newswire / March 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZY
Kirby McInerney LLP Announces Investigation Against Zynex, Inc. (ZYXI) on Behalf of Investors
08:00pm, Friday, 14'th Mar 2025
NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ:ZYXI). The investigati
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zynex, Inc. (“Zynex”
Zynex, Inc. (ZYXI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
02:00pm, Thursday, 13'th Mar 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the Company's
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) on behalf of investors concerning the Company
INVESTOR ALERT: Investigation of Zynex, Inc. (ZYXI) Announced by Holzer & Holzer, LLC
01:29pm, Wednesday, 12'th Mar 2025
ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) complied with federal securities laws. On March
Zynex's Sell-Off Creates A Speculative Buying Opportunity
11:12am, Wednesday, 12'th Mar 2025
Zynex, Inc. specializes in non-invasive pain management and patient monitoring, with promising advancements like the NiCO pulse oximeter targeting accurate readings for diverse skin tones. Despite dis
Zynex, Inc. (ZYXI) Q4 2024 Earnings Call Transcript
10:09pm, Tuesday, 11'th Mar 2025
Zynex, Inc. (NASDAQ:ZYXI ) Q4 2024 Earnings Conference Call March 11, 2025 4:15 PM ET Company Participants Brian Prenoveau - Investor Relations Thomas Sandgaard - Chairman of the Board, President, and
Zynex Inc. (ZYXI) Reports Q4 Loss, Misses Revenue Estimates
06:35pm, Tuesday, 11'th Mar 2025
Zynex Inc. (ZYXI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.04 per share a year ago.
Zynex delivers solid growth with rising orders and expanding product innovation
04:56pm, Tuesday, 11'th Mar 2025
Zynex Inc (NASDAQ:ZYXI) has reported its financial results for the fourth quarter and the full year 2024, with full-year revenue growing 4% to reach $192.4 million. The medical technology company spec
Zynex Reports Fourth Quarter and Full Year 2024 Financial Results
04:08pm, Tuesday, 11'th Mar 2025
ENGLEWOOD, Colo. , March 11, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Sets Fourth Quarter and Year End 2024 Earnings Call
09:15am, Monday, 03'rd Mar 2025
ENGLEWOOD, Colo. , March 3, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex COO on pain management innovations and growth plans – ICYMI
02:40pm, Friday, 28'th Feb 2025
Zynex Inc (NASDAQ:ZYXI) COO Anna Lucsok shared insights earlier this week about the company's operational strategies and future growth plans in an interview with Proactive. Lucsok discussed the compan
Zynex eyes FDA submission for NiCO oximeter as it expands portfolio of innovative medical devices
01:33pm, Tuesday, 28'th Jan 2025
Zynex Inc (NASDAQ:ZYXI) continues to expand its portfolio of innovative, non-invasive medical devices targeting pain management, rehabilitation, and pain monitoring. The company's flagship NexWave
Zynex partners with VA to offer pain management solutions for veterans
10:16am, Tuesday, 17'th Dec 2024
Zynex Inc (NASDAQ:ZYXI) has announced a new partnership with Veterans Affairs Medical Centers (VAMCs) across the United States, a significant opportunity to expand the reach of its noninvasive medical
